News Conference News TCT 2024 Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows Michael O'Riordan October 29, 2024
News Conference News ACC 2024 PREVENT Supports Early PCI for Vulnerable Plaque, With Reductions in MACE L.A. McKeown April 08, 2024
News Daily News PET-Guided Strategy Lowers Risk, Boosts Outcomes in Stable CAD: CENTURY Michael O'Riordan September 29, 2023
News Daily News Pitavastatin Cuts MACE in HIV-Infected Patients: REPRIEVE Michael O'Riordan July 25, 2023
News Daily News New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization Michael O'Riordan July 20, 2023
News Daily News LVEF Analysis Digs Anew Into Revascularization Benefits in Ischemic CAD Michael O'Riordan July 11, 2022
News Daily News New Chest Pain Guidelines Out at Last: Most Tests Have a Role Michael O'Riordan October 28, 2021
News Daily News OMT Boosts Survival in Revascularized Patients at 10 Years Michael O'Riordan June 29, 2021
News Daily News Based on Machine Learning, PRAISE Score Balances Risks in Post-ACS Care Yael L. Maxwell January 26, 2021
News Daily News AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More Shelley Wood December 17, 2020
News Daily News Plaque Burden, Not Coronary Stenosis, Linked to Future Events in Stable CAD Michael O'Riordan December 07, 2020
News Conference News TCT 2020 Under ISCHEMIA’s Long Shadow, Cardiologists Ponder Shifting Guidelines, Care Michael O'Riordan October 19, 2020
News Daily News Coronary CTA Should Be First When Assessing Stable CAD: Consensus Document Yael L. Maxwell September 10, 2020
News Conference News SCCT 2020 ISCHEMIA, Patient Age in PROMISE Among Top CT Papers of the Year at SCCT Yael L. Maxwell July 20, 2020
News Daily News Less MI, CV Death With Noninvasive Testing for Chest Pain: Observational Data Michael O'Riordan July 14, 2020
News Features Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019 Todd Neale December 10, 2019
News Daily News Highest Risk, Biggest Benefit in ACS Patients Treated With Alirocumab: ODYSSEY OUTCOMES Michael O'Riordan August 26, 2019
News Daily News Coronary CTA for Suspected CAD Shows Advantages in Predicting Hard Outcomes Over 10 Years Yael L. Maxwell October 23, 2018